Endothelium-Neutrophil Communication B1-Kinin Receptor-Bearing Microvesicles in Vasculitis.
作者信息
Tharaux Pierre-Louis, Dhaun Neeraj
机构信息
National Institute of Health and Medical Research, Paris Cardiovascular Centre, Paris, France
National Institute of Health and Medical Research, Paris Cardiovascular Centre, Paris, France.
出版信息
J Am Soc Nephrol. 2017 Aug;28(8):2255-2258. doi: 10.1681/ASN.2017030300. Epub 2017 Jul 14.
Abstract
摘要
相似文献
1
Endothelium-Neutrophil Communication B1-Kinin Receptor-Bearing Microvesicles in Vasculitis.血管炎中内皮细胞与中性粒细胞的通讯：携带B1-激肽受体的微泡
J Am Soc Nephrol. 2017 Aug;28(8):2255-2258. doi: 10.1681/ASN.2017030300. Epub 2017 Jul 14.
2
Microvesicle transfer of kinin B1-receptors is a novel inflammatory mechanism in vasculitis.微泡转移的缓激肽 B1 受体是血管炎中一种新的炎症机制。
Kidney Int. 2017 Jan;91(1):96-105. doi: 10.1016/j.kint.2016.09.023. Epub 2016 Dec 1.
3
C1-Inhibitor Decreases the Release of Vasculitis-Like Chemotactic Endothelial Microvesicles.C1抑制剂可减少血管炎样趋化性内皮微泡的释放。
J Am Soc Nephrol. 2017 Aug;28(8):2472-2481. doi: 10.1681/ASN.2016060637. Epub 2017 Mar 13.
4
Blockade of the kallikrein-kinin system reduces endothelial complement activation in vascular inflammation.阻断激肽释放酶-激肽系统可减少血管炎症中的内皮补体激活。
EBioMedicine. 2019 Sep;47:319-328. doi: 10.1016/j.ebiom.2019.08.020. Epub 2019 Aug 20.
5
Neutrophil-derived proteinase 3 induces kallikrein-independent release of a novel vasoactive kinin.中性粒细胞衍生的蛋白酶3诱导一种新型血管活性激肽的非激肽释放酶依赖性释放。
J Immunol. 2009 Jun 15;182(12):7906-15. doi: 10.4049/jimmunol.0803624.
6
Leukocyte-derived microvesicles dock on glomerular endothelial cells: stardust in the kidney.白细胞衍生的微泡与肾小球内皮细胞对接：肾脏中的星尘。
Kidney Int. 2017 Jan;91(1):13-15. doi: 10.1016/j.kint.2016.09.047.
7
Stimulated human neutrophils form biologically active kinin peptides from high and low molecular weight kininogens.受刺激的人类中性粒细胞可从高分子量和低分子量激肽原形成生物活性激肽肽。
J Leukoc Biol. 2004 Apr;75(4):631-40. doi: 10.1189/jlb.1103546. Epub 2004 Jan 23.
8
The contact/kinin and complement systems in vasculitis.血管炎中的接触/激肽系统和补体系统。
APMIS Suppl. 2009 Jun(127):48-54. doi: 10.1111/j.1600-0463.2009.02477.x.
9
New insights in the pathogenesis of immunoglobulin A vasculitis (Henoch-Schönlein purpura).免疫球蛋白 A 血管炎（过敏性紫癜）发病机制的新见解。
Autoimmun Rev. 2017 Dec;16(12):1246-1253. doi: 10.1016/j.autrev.2017.10.009. Epub 2017 Oct 14.
10
Altered neutrophil homeostasis in kinin B1 receptor-deficient mice.激肽B1受体缺陷小鼠中性粒细胞稳态的改变
Biol Chem. 2001 Jan;382(1):91-5. doi: 10.1515/BC.2001.014.
引用本文的文献
1
CD14 monocytes: the immune communication hub in early vasculitis symptoms of Kawasaki disease.CD14单核细胞：川崎病早期血管炎症状中的免疫通讯枢纽。
Front Immunol. 2025 Mar 26;16:1557231. doi: 10.3389/fimmu.2025.1557231. eCollection 2025.
2
Whole patient knowledge modeling of COVID-19 symptomatology reveals common molecular mechanisms.新冠病毒症状学的全患者知识建模揭示了常见分子机制。
Front Mol Med. 2023 Jan 4;2:1035290. doi: 10.3389/fmmed.2022.1035290. eCollection 2022.
3
Impaired Kallikrein-Kinin System in COVID-19 Patients' Severity.新冠肺炎患者严重程度的激肽释放酶-激肽系统受损。
Front Immunol. 2022 Jun 22;13:909342. doi: 10.3389/fimmu.2022.909342. eCollection 2022.
本文引用的文献
1
C1-Inhibitor Decreases the Release of Vasculitis-Like Chemotactic Endothelial Microvesicles.C1抑制剂可减少血管炎样趋化性内皮微泡的释放。
J Am Soc Nephrol. 2017 Aug;28(8):2472-2481. doi: 10.1681/ASN.2016060637. Epub 2017 Mar 13.
2
Microvesicle transfer of kinin B1-receptors is a novel inflammatory mechanism in vasculitis.微泡转移的缓激肽 B1 受体是血管炎中一种新的炎症机制。
Kidney Int. 2017 Jan;91(1):96-105. doi: 10.1016/j.kint.2016.09.023. Epub 2016 Dec 1.
3
Microvesicles in Autoimmune Diseases.自身免疫性疾病中的微囊泡。
Adv Clin Chem. 2016;77:125-175. doi: 10.1016/bs.acc.2016.06.005. Epub 2016 Jul 16.
4
Genetic variants in ANCA-associated vasculitis: a meta-analysis.抗中性粒细胞胞浆抗体相关性血管炎的遗传变异：一项荟萃分析。
Ann Rheum Dis. 2016 Sep;75(9):1687-92. doi: 10.1136/annrheumdis-2015-207601. Epub 2015 Oct 6.
5
Microvesicles as cell-cell messengers in cardiovascular diseases.微小囊泡作为心血管疾病中的细胞间信使。
Circ Res. 2014 Jan 17;114(2):345-53. doi: 10.1161/CIRCRESAHA.113.300858.
6
Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway.缓激肽介导疾病的发病机制：固有炎症途径的失调。
Adv Immunol. 2014;121:41-89. doi: 10.1016/B978-0-12-800100-4.00002-7.
7
Bradykinin receptor 1 activation exacerbates experimental focal and segmental glomerulosclerosis.缓激肽受体 1 激活加重实验性局灶节段性肾小球硬化。
Kidney Int. 2011 Jun;79(11):1217-27. doi: 10.1038/ki.2011.14. Epub 2011 Mar 16.
8
The plasma bradykinin-forming pathways and its interrelationships with complement.血浆缓激肽形成途径及其与补体的相互关系。
Mol Immunol. 2010 Aug;47(13):2161-9. doi: 10.1016/j.molimm.2010.05.010.
9
Blockade of the kinin B1 receptor ameloriates glomerulonephritis.阻断激肽 B1 受体可减轻肾小球肾炎。
J Am Soc Nephrol. 2010 Jul;21(7):1157-64. doi: 10.1681/ASN.2009090887. Epub 2010 May 6.
10
Neutrophil-derived proteinase 3 induces kallikrein-independent release of a novel vasoactive kinin.中性粒细胞衍生的蛋白酶3诱导一种新型血管活性激肽的非激肽释放酶依赖性释放。
J Immunol. 2009 Jun 15;182(12):7906-15. doi: 10.4049/jimmunol.0803624.
Zotero 插件